Our Recommendations
- Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring (2021)
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring (2021)
- Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men (2018)
- Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides (2021)
New Publications
- Identifying common opportunistic infections among people with advanced HIV disease (2024)
- Leveraging the Learning Insights from HIV Programming for Pregnant and Parenting Adolescent Girls (2023)
- Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV (2023)
- Point-of-care tests for sexually transmitted infections: target product profiles (2023)
- The role of HIV viral suppression in improving individual health and reducing transmission (2023)
Filter
337
Featured
Recommendations
13
New Publications
79
Language
Document type
No document type
120
Guidelines
112
Studies & Reports
59
Fact sheets
22
Infographics
9
Manuals
5
Situation Updates
3
Training Material
2
Resource Platforms
2
Brochures
1
Online Courses
1
Strategic & Response Plan
1
Countries / Regions
Latin America and the Carribbean
7
South Africa
7
Global
5
Africa
5
East and Southern Africa
5
Malawi
3
Asia
3
South–East Asia Region
3
Western and Central Europe
3
Uganda
3
Kenya
2
Lesotho
2
USA
2
Zambia
2
Nepal
1
El Salvador
1
Syria
1
Laos
1
Afghanistan
1
Zimbabwe
1
Philippines
1
Mozambique
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Jamaica
1
Bangladesh
1
Vietnam
1
Brazil
1
Sri Lanka
1
Russia
1
Yemen
1
Angola
1
Bhutan
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
HIV & STI
38
Policies & Guidelines HIV & TB
8
TB
8
Guidelines
7
Reproductive Health
6
Studies & Reports
5
Hepatitis
3
COVID-19
3
Women & Child Health
3
Capacity Building
3
Gynaecology & Obstetrics
3
Dermatology
2
Virology
2
Family Planning
1
x MEDBOX Issue Brief & Annual Reports x
1
Cervical Cancer
1
Chagas
1
Training Manuals
1
Demograhic Health Surveys DHS
1
Community Health
1
Information, Education and Communication (IEC)
1
Surgery & Anaesthesia
1
Nutrition
1
Maternal Health
1
Leishmaniasis
1
Non-communicable Diseases
1
Pharmacy & Technologies
1
Toolboxes
HIV testing & services
55
Clinical Aspects, Treatment & Prevention
49
Antiretroviral Treatment ART
46
Women
38
Clinical Aspects
36
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
35
ART Drug Resistance
25
Male Circumcision
23
HIV and COVID-19
23
COVID-19
22
Treatment Guidelines HIV
21
Opportunistic Infections
19
Prevention Guidelines
17
HIV service delivery
16
Access to treatment and laboratory
15
Co-Morbidities (except TB)
15
Treatment & Prevention
14
Policies
10
Prophylactic Treatment
10
Adherence
9
Testing Guidelines
8
Global Impact: Socio-economic, health services, TB & HIV
7
General Reports
6
Children & Adolescents
5
Community Worker
5
Eastern and Southern Africa
5
Drug resistance
4
Prevention of mother-to-child transmission (PMTCT)
4
Latin America & the Carribean
4
Others
3
Immunization Guidelines
3
Health Worker
3
Policies and guidelines
3
HIV in Key Populations
3
Eastern Europe and central Asia
3
Policies & Strategies
2
Prevention & Control
2
Global
2
Laboratory
2
Universal Health Coverage UHC and 90-90-90 Strategy
2
Country specific documents
2
Gender Aspects
2
TB/HIV
2
Asia and Pacific
2
HIV and coinfection
2
TB/HIV Coinfection
2
Reports & Studies Children HIV
2
Drugs
1
Adults
1
HIV surveillance
1
Substance Use Disorders, Others
1
Inclusion
1
HIV testing & disclosure
1
Transgender People
1
Sexually Transmitted Infections
1
Men who have sex with men (MSM)
1
HIV
1
People who injecting Drugs
1
HIV / AIDS
1
Reports
1
General
1
Clinical Guidelines
1
Online Courses & Resources
1
For Pregnant Women
1
Training, others
1
For Migrants & Refugees
1
Prison & Detention
1
For Older People
1
Hospital Readiness/Essential Health Services
1
COVID-19 Vaccination
1
Long-term Care Facilities
1
TB/COVID-19
1
Community Health Workers CHW
1
HIV &TB
1
Information Refugees Ukraine
1
Zoonoses
1
NTDs
1
Chagas
1
Clinical Aspects & Diagnostics
1
General Aspects
1
Malawi
1
For Community Health Workers
1
Nutrition
1
Research & Access
1
TB
1
Lobby and Advocacy
1
Depression
1
Prisoners
1
Contraceptive Dynamics Following HIV Testing
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at red...
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and...
An overview of validation structures and responsibilities at national, regional and global levels.
This governance document supplements the global guidance document. Validation of elimination requires rigorous assessment at the national, regional and global levels of the impact and process indicato...
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV and cervical cancer are inextricably linked. Women living with HIV are six times more likely to develop cervical cancer, which is o...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
All countries in the Latin American and Caribbean (LAC) region are expected to report on these indicators for the year 2022.
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...
Les pays progressent vers la réalisation de l’objectif mondial tendant à ce que, d’ici 2025, 95 pour cent des personnes qui vivent avec le VIH connaissent leur statut sérologique. Cependant, en 2020, on estimait encore à 6 millions le nombre de personnes séropositives non diagnostiquées da...
Les pays progressent vers la réalisation de l’objectif mondial tendant à ce que, d’ici 2025, 95 pour cent des personnes qui vivent avec le VIH connaissent leur statut sérologique. Cependant, en 2020, on estimait encore à 6 millions le nombre de personnes séropositives non diagnostiquées da...
National Guidelines on Nutrition, Care, Support, and Treatment (NCST) for Adolescents and Adults
These guidelines are intended to:
• Establish a consistent set of nutrition interventions and recommendations aimed at managing and preventing undernutrition and overnutrition in adolescents and ad...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of point-of-care diagnostic technologies for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vagi...
This updated manual provides a basic understanding of the principles of laboratory and point-of-care (POC) testing in the context of screening and diagnostic approaches, as well as antimicrobial susceptibility testing, as components of sexually transmitted infections (STIs) control. As with previous...
Pregnancy and childbirth during adolescence profoundly affects the lives of millions of girls worldwide, and is a leading cause of maternal mortality and morbidity, and infant and child mortality. Every year, an estimated 21 million girls aged 15–19 years old in low- and middle-income countries be...
Advanced HIV disease (defined in persons living with HIV with a CD4 cell count of <200cells/mm3 or presenting with a WHO Stage 3/4 AIDS-defining illness) poses a challenge to many countries globally and is responsible for significant mortality and morbidity among people living with HIV. In 2017, WHO...
